China
Africa
Explore chapters and articles related to this topic
Benign tumors
Published in Rashmi Sarkar, Anupam Das, Sumit Sethi, Concise Dermatology, 2021
This is also a solitary, uncommon cyst and a close differential of apocrine hidrocystoma. It has the skin of greyish-blue color, usually seen around the eyelids and cheeks. A history of an increase in size on exposure to heat and improvement when the skin is exposed to cold is present.
Tumors of Cutaneous Appendages
Published in Omar P. Sangueza, Sara Moradi Tuchayi, Parisa Mansoori, Saleha A. Aldawsari, Amir Al-Dabagh, Amany A. Fathaddin, Steven R. Feldman, Dermatopathology Primer of Cutaneous Tumors, 2015
Apocrine hidrocystoma (AH) typically presents as translucent, skin-colored to bluish cysts on the face and histologically as unilocular or multilocular cysts lined by epithelial cells that demonstrate apocrine decapitation.
Eyelid syringocystadenoma papilliferum: A novel presentation with major review
Published in Orbit, 2018
Michael C Tseng, Bijal Amin, Anne Barmettler
Twenty-six patients with SCAP of the eyelid were identified and their clinical features are summarized (see Table 1). Of these 26 patients, age at presentation ranged from 8 to 82 with the average age being 43.9 years, with five patients lacking demographic information. There were a larger number of women than men affected: 62% (n = 13/21) were female and 38% (n = 8/21) were male. The duration of these lesions prior to presentation was between 2 months and 70 years with an average duration of 24.3 years. Symptoms included recent rapid growth of the mass, localized swelling, pruritus, discomfort, and bleeding. On clinical examination, SCAP presents as fleshy, verrucous, ulcerated, crusted, nodular, papular, and cystic and the size ranges from 4 to 25 mm. Due to its nonspecific appearance, SCAP has been misdiagnosed as basal cell carcinoma, sebaceous cyst, recurrent chalazion, and hidrocystoma. On review of the literature, about a third of the cases are associated with benign lesions.14 Of these cases, no malignant transformations developed, and treatment with complete excision leads to no recurrence of the masses. Incomplete excisions, however, allowed tumor regrowth in three of three cases.
Treatment of benign eyelid lesions with Nd:YVO laser: a prospective study
Published in Journal of Cosmetic and Laser Therapy, 2020
Filipe Sousa-Neves, João Cardoso da Costa, Joana Braga, Sandra Prazeres
Of the 101 clinically benign conditions, 54 were found in the right eye. Female gender was significantly predominant, making a total of 62% of the sample (41 patients). Mean sample age was 55.4 ± 15.3 years (range: 18–86). All patients were Caucasian. Reported time from lesion appearance/presence and removal was 31 ± 23 months (range: from 6 to 84). Superior eyelid was the anatomical location of 51% of the conditions. Eyelid margin was involved in 15% of the cases and 11% were within 2 mm of the lacrimal punctum. The most commonly identified entity was papilloma, in 62 cases, followed by hidrocystoma in 18 (Figure 1).
Uses of eye drops in dermatology, literature review
Published in Journal of Dermatological Treatment, 2022
Sameh Magdy Sarsik, Heba Saed El-Amawy
Eccrine hidrocystoma (EH) is a benign cyst of the eccrine duct that affects mostly middle-aged women (76). Surgical removal is the conventional treatment for solitary syringomas; electrocauterization is another option, although both are unpleasant and may leave persistent pigmentation or scarring (77–79). Treatment of multiple lesions, on the other hand, can be difficult and has a wide range of responses and side effects. Oral atropine, while effective, is associated with systemic anticholinergic side effects that are usually intolerable to patients (80).